Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

If you’ve been waiting for the right time to support our work—that time is now.

Our mission is simple: To inform. To inspire. To ignite change for the common good.

But without the support of our readers, this model does not work and we simply won’t survive. It’s that simple.
We must meet our Mid-Year Campaign goal but we need you now.

Please, support independent journalism today.

Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year. Without your help, we won’t survive.

Sen. Rand Paul (R-Ky.) and his wife Kelley Paul attend a reception on January 19, 2017 in Washington, D.C. (Photo: Paul Morigi/Getty Images for Capitol File Magazine)

Sen. Rand Paul (R-Ky.) and his wife, Kelley Paul, attend a reception on January 19, 2017 in Washington, D.C. (Photo: Paul Morigi/Getty Images for Capitol File Magazine)

'Rand Paul Must Resign': Republican's Wife Bought Stock in Company Behind Covid Drug in Feb. 2020

"We've lost over 600,000 of our loved ones across this country," said progressive challenger Charles Booker. "Rand Paul knew how bad it would be, and he decided to choose profits instead of protecting you."

Kenny Stancil

Sixteen months after Congress' 45-day reporting deadline, Sen. Rand Paul on Wednesday disclosed that his wife bought stock in the pharmaceutical company that makes remdesivir, an antiviral drug used to treat Covid-19, on February 26, 2020—weeks after the Trump administration briefed the Senate Health Committee, of which the Kentucky Republican is a member, on the coronavirus but before the public had been made fully aware of its danger.

A spokesperson for Paul told the Washington Post that "the senator attended no briefings on Covid-19... [and] completed a reporting form for his wife's investment last year but learned only recently, while preparing an annual disclosure, that the form had not been transmitted."

That defense, however, wasn't enough to prevent critics from suggesting the Kentucky Republican ran afoul of ethical practices.

One of Paul's biggest critics was Charles Booker, a former Kentucky state lawmaker and progressive U.S. Senate candidate who is campaigning to unseat Paul in 2022. 

"Rand Paul must resign," Booker said in a video shared late Wednesday night. "We have learned that Senator Rand Paul has used this pandemic to put money in his pocket. We've lost over 600,000 of our loved ones across this country. Rand Paul knew how bad it would be, and he decided to choose profits instead of protecting you."

Paul "told you, 'Don't wear a mask,' and told you, 'Don't get the vaccine,'" Booker continued. "Is this why he didn't want you to wear a mask? Is this why he didn't want you to get a vaccine? Did he want you to get Covid? Did he want you to suffer?"

"We have to really ask these questions now," said Booker, "because how do you explain a member of the United States Senate having this information, knowing how deadly this virus would be, and instead of helping you—he voted against relief, continues to block it, continues to be in the way—bought stock in an antiviral drug that's supposed to treat people once they get Covid?"

"I'm blown away, y'all," Booker added. "There's the crime and then there's the cover-up. And the fact of the matter is, this is egregious and it speaks to exactly who Rand Paul is... he does not care whether we live or die, literally."

Booker was far from alone in questioning Paul's motives. As the Post noted:

Experts in corporate and securities law said the investment, and especially the delayed reporting of it, undermined trust in government and raised questions about whether the Kentucky Republican's family had sought to profit from nonpublic information about the looming health emergency and plans by the U.S. government to combat it. Several senators sold large amounts of stocks in January or February of last year, prompting a handful of insider-trading probes. 

One of last spring's most high-profile investigations of potential insider trading among members of Congress involved Kelly Loeffler, a former Republican senator from Georgia.

Noting that "getting suspended from YouTube [for one week for spreading misinformation about the effectiveness of masks in preventing the transmission of Covid-19] is the least of Rand's worries," Booker on Wednesday compared Paul's situation to that of Loeffler, who lost her election months later to Sen. Raphael Warnock (D-Ga.).

On Thursday, Rep. Alexandria Ocasio-Cortez (D-N.Y.) tweeted that "it is absolutely wild that members of Congress are still allowed to buy and sell individual stock."

"It shouldn't be legal," she said, adding that she and Reps. Joe Neguse (D-Colo.) and Raja Krishnamoorthi (D-Ill.) have introduced the Ban Conflicted Trading Act "to end the practice." 

Krishnamoorthi also pointed to the proposed legislation in response to the revelations about Paul's stock purchase. "Americans need to know their representatives are governing to help their constituents—not their own portfolios," he tweeted.

Like Loeffler and others, Paul probably would have faced scrutiny last year had he turned in his paperwork on time. Citing Paul's aide, the Post reported that the GOP lawmaker "sought guidance from the Senate Ethics Committee... and filed the supplemental report Wednesday along with the annual disclosure, which was due in May and submitted three months late."

According to the filing, Kelley Paul used her own savings to buy between $1,000 and $15,000 of stock in Gilead Sciences, the manufacturer of remdesivir.

The antiviral drug—which was invented a decade ago to treat hepatitis C and has been tested for possible use against Ebola and other infectious diseases—received an emergency use authorization from the Food and Drug Administration last May and was given to then-President Donald Trump during his bout with Covid-19 in October, before it obtained full approval.

A World Health Organization-backed study published last October "raised doubts about the drug's effectiveness, prompting the international agency to recommend against its use as a treatment for Covid-19," the Post reported. "That marked a reversal from its original position, laid out on February 24, 2020—two days before Kelley Paul's purchase—by a WHO assistant director general, who described remdesivir as the only known drug that 'may have real efficacy' in treating the novel virus."

"This is gross."
—Charles Booker, U.S. Senate candidate

"The National Institutes of Health began a clinical trial the next day," the newspaper noted. "The drug brought in $2.8 billion for Gilead last year."

As Common Dreams reported last year, progressives denounced Gilead for price-gouging remdesivir, which was developed with millions of dollars in taxpayer support

When Kelley Paul purchased stock in the company on February 26, 2020, it was worth $74.70 per share and climbed to more than $80 last March, which is when the WHO declared Covid-19 a pandemic. The price has since fallen to $70.14 as of Thursday.

Despite the fact that Paul's wife lost money on the investment, Booker argued the behavior reflects an unprincipled commitment to self-enrichment at the expense of the public good.

"This news," said Booker, "reminds me of exactly why these types of politicians fight to keep us fighting amongst ourselves. To keep us sick, blocking healthcare. To keep us poor. To keep us struggling while they put more money in their pockets."

"This is gross," he added. "This is so egregious that I am telling you right now—for the safety of our country, this commonwealth, our future—Rand Paul needs to resign immediately."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

"I'm sure this will be all over the corporate media, right?"
That’s what one longtime Common Dreams reader said yesterday after the newsroom reported on new research showing how corporate price gouging surged to a nearly 70-year high in 2021. While major broadcasters, newspapers, and other outlets continue to carry water for their corporate advertisers when they report on issues like inflation, economic inequality, and the climate emergency, our independence empowers us to provide you stories and perspectives that powerful interests don’t want you to have. But this independence is only possible because of support from readers like you. You make the difference. If our support dries up, so will we. Our crucial Mid-Year Campaign is now underway and we are in emergency mode to make sure we raise the necessary funds so that every day we can bring you the stories that corporate, for-profit outlets ignore and neglect. Please, if you can, support Common Dreams today.

 

'We Need Action': Biden, Democrats Urged to Protect Abortion Access in Post-Roe US

"The Supreme Court doesn't get the final say on abortion," Sens. Elizabeth Warren and Tina Smith wrote in a new op-ed.

Kenny Stancil ·


Motorist 'Tried to Murder' Abortion Rights Advocates at Iowa Protest, Witnesses Say

Although one witness said the driver went "out of his way" to hit pro-choice protestors in the street, Cedar Rapids police declined to make an arrest.

Kenny Stancil ·


'A Hate Crime': Oslo Pride Parade Canceled After Deadly Shooting at Gay Bar

A 42-year-old gunman has been charged with terrorism following what Norway's prime minister called a "terrible and deeply shocking attack on innocent people."

Kenny Stancil ·


'We WILL Fight Back': Outrage, Resolve as Protests Erupt Against SCOTUS Abortion Ruling

Demonstrators took to the streets Friday to defiantly denounce the Supreme Court's right-wing supermajority after it rescinded a constitutional right for the first time in U.S. history.

Brett Wilkins ·


80+ US Prosecutors Vow Not to Be Part of Criminalizing Abortion Care

"Criminalizing and prosecuting individuals who seek or provide abortion care makes a mockery of justice," says a joint statement signed by 84 elected attorneys. "Prosecutors should not be part of that."

Kenny Stancil ·

Common Dreams Logo